Literature DB >> 9613640

Investigation of cross contamination in a Mycobacterium tuberculosis laboratory using IS6110 DNA fingerprinting.

J M Van Duin1, J E Pijnenburg, C M van Rijswoud, P E de Haas, W D Hendriks, D van Soolingen.   

Abstract

SETTING: A laboratory for routine culturing of Mycobacterium tuberculosis.
OBJECTIVE: Investigation of an episode of laboratory cross contamination using IS6110 restriction fragment length polymorphism (RFLP) typing. Improvement of laboratory protocols to prevent contaminations in the future. To stress the importance of 'good laboratory practice', and interaction with clinicians about laboratory results.
DESIGN: Fingerprinting of mycobacterial isolates from 1) cultures suspected of being contaminated and 2) strains suspected of being the source of the cross-contamination.
RESULTS: RFLP typing results indicated that clinical samples were contaminated by strains which had been processed in species identification procedures one day earlier in the same safety cabinet. This cross contamination also resulted in exceptional RFLP typing results--mixed banding patterns. Three patients were treated on the basis of false-positive laboratory results. Because the laboratory results were confusing for the clinicians, the treatment of one true tuberculosis patient was severely delayed.
CONCLUSION: 'Good laboratory practice' is very important to prevent cross contamination. RFLP typing proved to be a useful tool to trace the source of contamination. Interaction with clinicians receiving doubtful results is of the utmost importance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9613640

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  False-positive mycobacterium tuberculosis cultures in 44 laboratories in The Netherlands (1993 to 2000): incidence, risk factors, and consequences.

Authors:  Annette S de Boer; Barbara Blommerde; Petra E W de Haas; Maruschka M G G Sebek; Kitty S B Lambregts-van Weezenbeek; Mirjam Dessens; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Genetic heterogeneity in Mycobacterium tuberculosis isolates reflected in IS6110 restriction fragment length polymorphism patterns as low-intensity bands.

Authors:  A S de Boer; K Kremer; M W Borgdorff; P E de Haas; H F Heersma; D van Soolingen
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Molecular characterization of Mycobacterium tuberculosis H37Rv/Ra variants: distinguishing the mycobacterial laboratory strain.

Authors:  P Bifani; S Moghazeh; B Shopsin; J Driscoll; A Ravikovitch; B N Kreiswirth
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

4.  Infrequent MODS TB culture cross-contamination in a high-burden resource-poor setting.

Authors:  David A J Moore; Luz Caviedes; Robert H Gilman; Jorge Coronel; Fanny Arenas; Doris LaChira; Cayo Salazar; Juan Carlos Saravia; Richard A Oberhelman; Maria-Graciela Hollm-Delgado; A Roderick Escombe; Carlton A W Evans; Jon S Friedland
Journal:  Diagn Microbiol Infect Dis       Date:  2006-05-06       Impact factor: 2.803

5.  A prospective, multicenter study of laboratory cross-contamination of Mycobacterium tuberculosis cultures.

Authors:  Robert M Jasmer; Marguerite Roemer; John Hamilton; John Bunter; Christopher R Braden; Thomas M Shinnick; Edward P Desmond
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

6.  DNA fngerprinting of Mycobacterium tuberculosis: lessons learned and implications for the future.

Authors:  Scott J N McNabb; Christopher R Braden; Thomas R Navin
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

7.  Development and evaluation of an in-house single step loop-mediated isothermal amplification (SS-LAMP) assay for the detection of Mycobacterium tuberculosis complex in sputum samples from Moroccan patients.

Authors:  El Mehdi Bentaleb; Mohammed Abid; My Driss El Messaoudi; Brahim Lakssir; El Mostafa Ressami; Saaïd Amzazi; Hassan Sefrioui; Hassan Ait Benhassou
Journal:  BMC Infect Dis       Date:  2016-09-27       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.